After years of reports, Instagram restricted some hashtags and accounts apparently related to opioid sales, after activist confronted Facebook execs last week
Nitasha Tiku / Wired : Tweets: @nitashatiku , @robleathern , @robleathern , @eileenmcarey , and @eileenmcarey Tweets: Nitasha Tiku / @nitashatiku : How do you get Facebook to better police illegal opioid sales during an epidemic? Tweet at their execs http://www.wired.com/... Rob Leathern / @robleathern : (We have long-running efforts at addressing fake accounts unrelated to politics) we are looking into these posts Rob Leathern / @robleathern : We took several accounts down in association with this - thank you for reporting Eileen Carey / @eileenmcarey : I've been diligently reporting and flagging accounts on instagram that are selling opioids. they aren't getting taken down. They don't meet the FB criteria for ‘fake accounts’ but they are advertising illegal drugs through a instagram & WhatsApp marketplace, search #fentanyl pic.twitter.com/uVEd5swNat Eileen Carey / @eileenmcarey : Great. eBay & Craigslist actively removed this black market years ago via IP monitoring. IG removes nipple photos, but not pill photos or pharma trademark abuse. IG dealers aren't ‘fake’ users but ‘fake’ pharma distributors.These flagged accounts are still selling kids opioids pic.twitter.com/TZ5wlgK55Q
Context & Ripple Effects
Eileen Carey had been reporting opioid-selling accounts on Instagram repeatedly without result; when she confronted Facebook executives publicly last week, product integrity exec Rob Leathern replied within days that several accounts were taken down and certain hashtags restricted. The move lands amid growing documentation of the problem — BuzzFeed's later examination of how social networks host illegal prescription-drug sales despite Terms of Service forbidding it ([[a:930191]]) shows the gap between policy and enforcement.
First-order effects
- Sellers who relied on opioid-related hashtags and accounts for reach lose those discovery channels immediately, as Leathern confirmed several account removals tied directly to Carey's reports.
- Carey's reporting path — tagging executives publicly rather than using in-app tools — is validated as the mechanism that finally triggered action.
Second-order effects
- Enforcement broadens from individual accounts to infrastructure: by August, Facebook said it had begun removing drug-policy-violating content and blocking hundreds of search terms and suggestions ([[a:932504]]), and Instagram followed with help resources shown to users searching drug hashtags ([[a:933328]]).
- Other platforms face the same activist-and-press playbook, raising the cost of leaving drug-sale content up once one network acts visibly.
Third-order effects
- Reactive, pressure-driven enforcement proves structurally insufficient: a 2024 investigation still found 450+ illicit drug ads running on Facebook and Instagram ([[a:871918]]), and regulators have since moved toward examining platforms' roles in drug sales directly, as with the FBI and DOJ looking at Snapchat's part in fentanyl-laced pill distribution ([[a:834443]]).
The trend: Platform policing of illegal drug commerce is converging from ad-hoc, activist-triggered takedowns toward regulatory scrutiny as enforcement gaps persist across networks.